| [1] |
HUANG Yaqin, XUE Rong.
Treatment of sleep disorder in patients with acute cerebrovascular disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 516-521.
|
| [2] |
YANG Yi-Chao, LI Su-Yong.
Clinical efficacy of naloxone in treatment ofPatients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 708-709.
|
| [3] |
WEI Qing-Yang, YUE Hui-Fang.
Clinical therapeutic effects oflow molecular weight heparin combined with xiangdan inPatients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 465-467.
|
| [4] |
WU Yun-Xia, ZHAO Min, ZHANG Qing-Chun, ZHAO Yun.
Clinical efficacy of large dosage of liyuan pure lysothrombusase in the treatment of acute cerebral infarct
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(4): 353-354.
|
| [5] |
GUO Zhong.
Selection of drugs in the treatment of acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(4): 357-358.
|
| [6] |
WANG De-Bao, LU Deng-Cai, ZHANG Feng-Mei.
Treatment of 52 cases with diabetic derebral infarction by prostaglandin E1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(1): 65-66.
|
| [7] |
BAO Zheng-She.
Clinical analysis of intravenous infusion of fibrinolytic agent in the treatment of acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(3): 252-255.
|
| [8] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(3): 256-258.
|
| [9] |
Gong Peili, Fang Siyu, Wei Guirong, Liu Guheng, Zng Fandian.
Clinical evaluation of treatment of acute ischemic cerebreal infarction with intravenous nimodipine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1996, 1(1): 4-7.
|
